{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:23:03Z","timestamp":1792545783128,"version":"4.5.0"},"reference-count":80,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Pulmonary hypertension (PH) caused by left heart disease, also known as post-capillary PH, is the most common etiology of PH. Left heart disease due to systolic dysfunction or heart failure with preserved ejection fraction, valvular heart disease, and left atrial myopathy due to atrial fibrillation are causes of post-capillary PH. Elevated left-sided filling pressures cause pulmonary venous congestion due to backward transmission of pressures and post-capillary PH. In advanced left-sided heart disease or valvular heart disease, chronic uncontrolled venous congestion may lead to remodeling of the pulmonary arterial system, causing combined pre-capillary and post-capillary PH. The hemodynamic definition of post-capillary PH includes a mean pulmonary arterial pressure &gt; 20 mmHg, pulmonary vascular resistance &lt; 3 Wood units, and pulmonary capillary wedge pressure &gt; 15 mmHg. Echocardiography is important in the identification and management of the underlying cause of post-capillary PH. Management of post-capillary PH is focused on the treatment of the underlying condition. Strategies are geared towards pharmacotherapy and guideline-directed medical therapy for heart failure, surgical or percutaneous management of valvular disorders, and control of modifiable risk factors and comorbid conditions. Referral to centers with advanced heart and pulmonary teams has shown to improve morbidity and mortality. There is emerging interest in the use of targeted agents classically used in pulmonary arterial hypertension, but current data remain limited and conflicting. This review aims to serve as a comprehensive summary of postcapillary PH and its etiologies, pathophysiology, diagnosis, and management, particularly as it pertains to advanced heart failure.<\/jats:p>","DOI":"10.3390\/jcm13020625","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T11:36:41Z","timestamp":1705923401000},"page":"625","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Post-Capillary Pulmonary Hypertension: Clinical Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6544-1606","authenticated-orcid":false,"given":"Joshua M.","family":"Riley","sequence":"first","affiliation":[{"name":"Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19147, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Fradin","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19147, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas H.","family":"Russ","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19147, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Warner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19147, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniy","family":"Brailovsky","sequence":"additional","affiliation":[{"name":"Jefferson Heart Institute, Thomas Jefferson University Hospital, Philadelphia, PA 19147, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranee","family":"Rajapreyar","sequence":"additional","affiliation":[{"name":"Jefferson Heart Institute, Thomas Jefferson University Hospital, Philadelphia, PA 19147, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10741-020-09935-x","article-title":"A right ventricular state of mind in the progression of heart failure with reduced ejection fraction: Implications for left ventricular assist device therapy","volume":"26","author":"DeFilippis","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Adir","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e003973","DOI":"10.1161\/CIRCOUTCOMES.117.003973","article-title":"Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension","volume":"11","author":"Wijeratne","year":"2018","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: A community-based study","volume":"31","author":"Lam","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201503-0529OC","article-title":"Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival","volume":"192","author":"Gerges","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jchf.2013.05.001","article-title":"Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: Pulmonary hypertension and heart failure","volume":"1","author":"Miller","year":"2013","journal-title":"JACC Heart Fail."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2006.11.052","article-title":"Prognostic importance of pulmonary hypertension in patients with heart failure","volume":"99","author":"Kjaergaard","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","article-title":"Association of Borderline Pulmonary Hypertension with Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups","volume":"36","author":"Gall","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/CIRCHEARTFAILURE.114.001276","article-title":"Left atrium in heart failure with preserved ejection fraction: Structure, function, and significance","volume":"7","author":"Rossi","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week","volume":"76","author":"Guazzi","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.115.016795","article-title":"Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate","volume":"132","author":"Goldberger","year":"2015","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.111.051540","article-title":"Pulmonary capillary wedge pressure augments right ventricular pulsatile loading","volume":"125","author":"Tedford","year":"2012","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/HYPERTENSIONAHA.119.14330","article-title":"Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy","volume":"75","author":"Sugito","year":"2020","journal-title":"Hypertension"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","article-title":"Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives","volume":"69","author":"Guazzi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1093\/eurheartj\/ehac184","article-title":"Pulmonary vascular disease in pulmonary hypertension due to left heart disease: Pathophysiologic implications","volume":"43","author":"Omote","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: A systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1183\/13993003.00741-2015","article-title":"Pulmonary vascular resistance and compliance relationship in pulmonary hypertension","volume":"46","author":"Chemla","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: A retrospective cohort study","volume":"8","author":"Maron","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.jacc.2020.10.007","article-title":"Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week","volume":"76","author":"Maron","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e009362","DOI":"10.1161\/JAHA.118.009362","article-title":"Lack of a Tricuspid Regurgitation Doppler Signal and Pulmonary Hypertension by Invasive Measurement","volume":"7","author":"Assad","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1164\/rccm.201004-0601OC","article-title":"Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension","volume":"183","author":"Arkles","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/echo.13699","article-title":"Differences in right ventricular morphology, not function, indicate the nature of increased afterload in pulmonary hypertensive subjects with normal left ventricular function","volume":"34","author":"Raza","year":"2017","journal-title":"Echocardiography"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Humbert","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jamacardio.2017.2945","article-title":"Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University","volume":"2","author":"Opotowsky","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1183\/16000617.0062-2015","article-title":"Right heart catheterisation: Best practice and pitfalls in pulmonary hypertension","volume":"24","author":"Rosenkranz","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21693\/1933-088X-10.1.33","article-title":"The Nuts and Bolts of Interpreting Hemodynamics in Pulmonary Hypertension Associated With Diastolic Heart Failure","volume":"10","author":"Mathier","year":"2011","journal-title":"Adv. Pulm. Hypertens."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1378\/chest.10-0981","article-title":"Effect of Balloon Inflation Volume on Pulmonary Artery Occlusion Pressure in Patients With and Without Pulmonary Hypertension","volume":"139","author":"Tonelli","year":"2011","journal-title":"Chest"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e22683","DOI":"10.1097\/MD.0000000000022683","article-title":"Echocardiographic evaluation of left ventricular end diastolic pressure in patients with diastolic heart failure","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.08-2784","article-title":"Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure","volume":"136","author":"Halpern","year":"2009","journal-title":"Chest"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jchf.2017.08.005","article-title":"Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction","volume":"5","author":"Mascherbauer","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.hfc.2013.05.002","article-title":"Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: Academics\u2019, clinicians\u2019, industry\u2019s, regulators\u2019, and payers\u2019 perspectives","volume":"9","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail. Clin."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned From Hospitalized Heart Failure Registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ejhf.516","article-title":"Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency","volume":"18","author":"Anker","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000107791","article-title":"Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension\u2014A multi-center randomized study","volume":"109","author":"Kaluski","year":"2008","journal-title":"Cardiology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ejhf.47","article-title":"Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: A meta-analysis","volume":"16","author":"Wu","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for Heart Failure with Preserved Ejection Fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1701886","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","volume":"51","author":"Delcroix","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hlc.2016.09.004","article-title":"Pilot Study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial)","volume":"26","author":"Koller","year":"2017","journal-title":"Heart Lung Circ."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","article-title":"Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: A randomized controlled trial","volume":"36","author":"Hoendermis","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.chest.2019.07.028","article-title":"Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile","volume":"157","author":"Crawford","year":"2020","journal-title":"Chest"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J. Heart. Lung Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.hlc.2018.04.299","article-title":"Left Ventricular Assist Devices in Pulmonary Hypertension Group 2 With Significantly Elevated Pulmonary Vascular Resistance: A Bridge to Cure","volume":"28","author":"Selim","year":"2019","journal-title":"Heart Lung Circ."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cardfail.2016.06.421","article-title":"Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation","volume":"23","author":"Farhoud","year":"2017","journal-title":"J. Card. Fail."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e003882","DOI":"10.1161\/CIRCHEARTFAILURE.117.003882","article-title":"Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation","volume":"10","author":"Imamura","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCULATIONAHA.115.015853","article-title":"Dose\u2013Response Relationship Between Physical Activity and Risk of Heart Failure","volume":"132","author":"Pandey","year":"2015","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0735-1097(01)01195-0","article-title":"Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction","volume":"37","author":"Suskin","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"SPRINT Research Group (2015). A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl. J. Med., 373, 2103\u20132116.","DOI":"10.1056\/NEJMoa1511939"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/hrt.2004.048389","article-title":"Systematic review of multidisciplinary interventions in heart failure","volume":"91","author":"Holland","year":"2005","journal-title":"Heart"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e002358","DOI":"10.1161\/CIRCINTERVENTIONS.114.002358","article-title":"Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Patients With Severe Symptomatic Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation","volume":"8","author":"Wenaweser","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ejhf.864","article-title":"Implication of pulmonary hypertension in patients undergoing MitraClip therapy: Results from the German transcatheter mitral valve interventions (TRAMI) registry","volume":"20","author":"Tigges","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.amjmed.2017.05.003","article-title":"Pulmonary Hypertension with Left Heart Disease: Prevalence, Temporal Shifts in Etiologies and Outcome","volume":"130","author":"Weitsman","year":"2017","journal-title":"Am. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcmg.2014.12.003","article-title":"Pulmonary Hypertension in Valvular Disease","volume":"8","author":"Magne","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_72","first-page":"e35","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jtcvs.2016.02.038","article-title":"The impact of concomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis","volume":"152","author":"Yang","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9149(58)90244-3","article-title":"Clinical and hemodynamic observations in pure mitral insufficiency","volume":"2","author":"Ross","year":"1958","journal-title":"Am. J. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jtcvs.2010.11.031","article-title":"Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation","volume":"142","author":"Kainuma","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.echo.2006.03.016","article-title":"Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: An echocardiographic and hemodynamic study","volume":"19","author":"Yang","year":"2006","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/hrt.2009.186486","article-title":"Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation","volume":"96","author":"Richardson","year":"2010","journal-title":"Heart"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/heartjnl-2017-311506","article-title":"The role and clinical implications of diastolic dysfunction in aortic stenosis","volume":"103","author":"Kampaktsis","year":"2017","journal-title":"Heart"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCINTERVENTIONS.113.000482","article-title":"Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation","volume":"7","author":"Oger","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0002-9149(99)00643-8","article-title":"Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis","volume":"85","author":"Faggiano","year":"2008","journal-title":"Am. J. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/2\/625\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:47:08Z","timestamp":1760104028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/2\/625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":80,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["jcm13020625"],"URL":"https:\/\/doi.org\/10.3390\/jcm13020625","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}